Insider filing · ARTV
Fred Aslan
President and CEO
profile →
Artiva Biotherapeutics, Inc.
ARTV · Healthcare · 15 filings in 24 months
ticker →
Fred Aslan sold $256K of Artiva Biotherapeutics (ARTV)
Executed Sep 8, disclosed Sep 9, 1 day later.
Value, as filed
$256K
23,429 sh × $10.92
Executed
Sep 8
the trade date, as filed
Disclosed
Sep 9
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
FAFred Aslan (President and CEO) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Artiva Biotherapeutics, Inc. (ARTV). The largest single filing was $690K of ARTV (61,888 sh × $11.16, as filed), executed Sep 3.
The name
ARTVHealthcare · Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for pa…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Fred Aslan in ARTV
ARTVSALE
Artiva Biotherapeutics, Inc.
$690K61,888 sh × $11.16
Exec Sep 3
Filed Sep 4 · 4:02 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $244K
27,116 sh × $9.01
Exec May 19
Filed May 19 · 5:30 PM ET ARTVSALE Artiva Biotherapeutics, Inc. $153K
25,500 sh × $6.00
Exec Oct 17 2025
Filed Oct 17 2025 · 5:30 PM ET